Friday 6 November 2026 Export BMRN’s income statement to Excel — free account

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 12.9% from fiscal 2024.

Revenue: +32.0%
EPS: −296.6%
Free cash flow: −52.3%
Total debt: +599.5%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

55.89 0.23 −0.41%

Follow BMRN

Alert me

Market cap: $10.9B
P/E: 0.0×
Fwd P/E: 32.7×
Dividend yield: —
F-score: 5/9
Altman Z: 5.67
Beneish M: −2.49
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	4	3	2
ROE Full definition →		5.94%	4.48%	1.18%	(0.31%)
ROA Full definition →		4.79%	3.42%	0.76%	(0.20%)
ROIC Full definition →		5.00%	3.64%	0.97%	0.73%
Return on Tangible Assets Full definition →		8.41%	5.63%	2.21%	(0.58%)
Average Days of Receivables Full definition →		102.91	101.76	113.69	107.48
Free Cash Flow per Share Full definition →		3.74	3.98	3.75	2.88
Free Cash Flow Full definition →		717.02	767.06	724.81	557.86
Capital Expenditures Full definition →		(110.97)	(107.19)	(132.28)	(118.75)
Other line items
Cash ROIC Full definition →		8.70%	7.78%	6.37%	5.00%
Accounts Receivable Turnover Full definition →		4.11	3.95	3.55	3.92
Accounts Payable Turnover Full definition →		1.05	1.07	0.96	1.01
Inventory Turnover Full definition →		0.57	0.60	0.52	0.55
Average Days of Payables Full definition →		386.16	380.48	451.23	392.90
Days of Inventory on Hand Full definition →		660.81	610.77	799.69	745.88
Tax Rate Full definition →		(0.28)	(0.30)	(0.51)	(1.44)
Research and Development Expense of Revenue Full definition →		28.62%	29.05%	28.99%	26.80%
Selling, General and Administrative Expense of Revenue Full definition →		35.79%	37.17%	40.17%	39.22%
Share Based Compensation of Revenue Full definition →		5.63%	5.77%	6.32%	6.01%
Interest Coverage Full definition →		37.57	13.71	1.79	0.83
Operating CF/Net income Full definition →		2.37	3.25	11.75	(35.40)
Depreciation/Fixed assets Full definition →		0.08	0.07	0.15	0.27
Capex/Depreciation Full definition →		(1.48)	(1.53)	(0.89)	(0.46)
Revenue per Share Full definition →		16.80	16.84	17.61	18.88
Operating CF per Share Full definition →		4.32	4.54	4.43	3.50
Capex per Share Full definition →		(0.58)	(0.56)	(0.68)	(0.61)
Capex to Sales Full definition →		0.03	0.03	0.04	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly